OMER
USDOmeros Corporation Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$7.060
High
$7.240
Low
$6.710
Volume
1.29M
Company Fundamentals
Market Cap
458.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
3.30M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's experimental drug, which is being developed for rare blood and kidney disorders, they said on Wednesday.
Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros' clinical-stage MASP-3 inhibitor zaltenibart (OMS906)
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk's Rare Disease portfolioOmeros is eligible to receive 340 million US dollars in upfront and near-term
Related Stocks
BGB
Blackstone Strategic Credit 2027 Term Fund Common Shares of Beneficial Interest
RSVR
Reservoir Media Inc.
CTXR
Citius Pharmaceuticals Inc.
PWUP
PowerUp Acquisition Corp. Ordinary Shares
HGTY
Hagerty Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.